[ 1 ] Black RE, Cousens S, Johnson HL, et al. Global, regional, and National causes of child mortality in 2008: a systematic analysis[J]. Lancet, 2010, 375(9730): 1969-1987.
[2]
[ 2 ] Fischer Walker CL, Black RE. Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size[J]. BMC Public Health, 2011, 11(Suppl 3): S16.
[3]
[ 3 ] Khatib PK, Khan ZH. Prevalence of rotavirus diarrhoea among childrens in Akola[J]. Int J Pharm Res Allied Sci, 2013, 2(1): 65-69.
[4]
[ 4 ] Parashar UD, Alexander JP, Glass RI, et al. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)[J]. MMWR Recomm Rep, 2006, 55(RR/12): 1-13.
[ 9 ] Lee SY, Hong JH, Lee SW, et al. Comparisons of latex agglutination, immunochromatography and enzyme immunoassay methods for the detection of rotavirus antigen[J]. Korean J Lab Med, 2007, 27(6): 437-441.
[10]
Díaz Y, Pe？a F, Aristimu？o OC, et al. Dissecting the Ca2+ entry pathways induced by rotavirus infection and NSP4-EGFP expression in Cos-7 cells[J]. Virus Res, 2012, 167(2): 285-296.
[11]
Lorrot M, Vasseur M. How do the rotavirus NSP4 and bacterial enterotoxins Lead differently to diarrhea[J]. Virol J, 2007, 4(1): 31.
Petri WA, Miller M, Binder HJ, et al. Enteric infections, diarrhea, and their impact on function and development[J]. J Clin Invest, 2008, 118(4): 1277-1290.
[14]
Zambrano JL, Sorondo O, Alcala A, et al. Rotavirus infection of cells in culture induces activation of RhoA and changes in the actin and tubulin cytoskeleton[J]. PLoS One, 2012, 7(10): e47612.
[15]
Kordasti S, Sj？vall H, Lundgren O, et al. Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea[J]. Gut, 2004, 53(7): 952-957.
[16]
Pant N, Hultberg A, Zhao Y, et al. Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea[J]. J Infect Dis, 2006, 194(11): 1580-1588.
[17]
Martín MC, Pant N, Ladero V, et al. Integrative expression system for delivery of antibody fragments by lactobacilli[J]. Appl Environ Microbiol, 2011, 77(6): 2174-2179.
[18]
Ball JM, Mitchell DM, Gibbons TF, et al. Rotavirus NSP4: a multifunctional viral enterotoxin[J]. Viral Immunol, 2005, 18(1): 27-40.
[19]
Lundgren O, Svensson L. The enteric nervous system and infectious diarrhea[M]//Desselberger U, Gray J. Viral gastroenteritis. Amsterdam: Elsevier Science BV, 2003: 51-68.
[20]
Parsa-Nahad M, Samarbaf-Zadeh A, Makvandi M, et al. Determination of rotavirus, sapovirus and norovirus coinfection among children suffering from gastroenteritis[J]. Iran J Virol, 2011, 5(4): 29-31.
[21]
Orenstein EW, Fang ZY, Xu J, et al. The epidemiology and burden of rotavirus in China: a review of the literature from 1983 to 2005[J]. Vaccine, 2007, 25(3): 406-413.
[22]
Yang XL, Matthijnssens J, Sun H, et al. Temporal changes of rotavirus strain distribution in a city in the northwest of China, 1996-2005[J]. Int J Infect Dis, 2008, 12(6): e11-e17.
[23]
Dennehy PH. Rotavirus infection: an update on management and prevention[J]. Adv Pediatr, 2012, 59(1): 47-74.
[24]
Patel MM, Clark AD, Glass RI, et al. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception[J]. Vaccine, 2009, 27(22): 2916-2922.
[25]
Nakagomi O, Cunliffe NA. Rotavirus vaccines: entering a new stage of deployment[J]. Curr Opin Infect Dis, 2007, 20(5): 501-507.
[26]
Dennehy PH. Rotavirus infection: an update on management and prevention[J]. Adv Pediatr, 2012, 59(1): 47-74.
[27]
Dumoulin M, Last AM, Desmyter A, et al. A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme[J]. Nature, 2003, 424(6950): 783-788.
